“Chemistry is the basis of all life on Earth, the driving force that makes our bodies tick. Figuring out how to leverage these forces to improve healthcare has always been fascinating for me,” says Dr Rachel Wang, a Harvard Medical School alumna. After she was introduced to NTU Professor Anand Asundi and his pioneering work on 4D biomedical imaging technologies, the pair co-founded d’Optron, which produces innovative optronics systems that enable quantitative 4D imaging over a wide range of applications, such as microelectronics, biomedicine, and precision engineering.
Its inventions include the d’Biomager, which is a microsope camera that converts 2D images into 4D videos. This technology is a giant leap forward for the biomedical and healthcare industries as it allows the size and volume of cells to be tracked in real time. This innovation clinched the AMA Young Enterprise Award 2016 — a first for a Singaporean start-up — and big industry players such as Samsung, Carl Zeiss and Polytec have expressed their interest.
“Taking a new technology as if it is an unpolished gemstone and shaping it into a precious gem that will benefit mankind gives me indescribable satisfaction,” says Wang.